Athelas
Company

Last deal

$59.4M

Amount

Venture - Series Unknown

Stage

31.01.2022

Date

4

all rounds

$146.4M

Total amount

General

About Company
Athelas develops technology to monitor chronically ill patients in their homes.

Industry

Sector :

Subsector :

Keywords :

founded date

01.06.2016

Number of employees

Company Type

For Profit

Last funding type

Venture - Series Unknown

IPO status

Private

Description

Athelas has developed an in-home blood diagnostic device that analyzes blood cells and generates diagnostic reports, along with other sensors to manage Blood Pressure, Weight, Glucose, and Medication Adherence. The company aims to bring hospital-grade tools to the home, and also offers Revenue Cycle Management (RCM) and Remote Patient Monitoring (RPM) services to healthcare providers, allowing them to monitor patient vitals and manage billing and reimbursements more efficiently.
Contacts